# Jacobs wins construction management contract for WuXi Biologics facility in Ireland

Jacobs has been selected to provide construction management services for WuXi Biologics' new biologics drug substance manufacturing facility in Dundalk, Ireland. The facility is estimated to cost more than $394 million and will create 400 highly skilled jobs.

- Type: Contract
- Announced: 2019-05-21
- Where: Dundalk, Co. Louth, Ireland, Ireland
- Value: $394.0M
- Jobs: 400
- Status: announced
- Products: biologic drugs
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Jacobs](https://endata.com/companies/15664.md)
- [WuXi Biologics](https://endata.com/companies/31607.md) (customer)

## Sources

- [biospace.com](https://www.biospace.com/jacobs-wins-contract-to-provide-construction-phase-services-for-wuxi-biologics-biomanufacturing-facility), 2019-05-21: "Jacobs has been selected to provide construction management services for global biologics leader, WuXi Biologics, to support the development of its new biologics drug substance manufacturing facility located in Dundalk, Co. Louth, Ireland."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.